SCHEMBL5659737

SCHEMBL5659737

CC(=O)Nc1ccc(CCNCCCCNCC(=O)Nc2ccc(Oc3ccccc3)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.62
RECQL P46063 1/20 0.58
KDM4E B2RXH2 2/20 0.57
RNF4 P78317 1/20 0.51
POLB P06746 1/20 0.50
PKM P14618 1/20 0.50
HDAC1 Q13547 3/20 0.49
HDAC2 Q92769 2/20 0.49
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPY5R Q15761 1/20 0.47
GAA P10253 2/20 0.47
EPHX2 P34913 1/20 0.46
LMNA P02545 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5658879 0.91 RECQL (0.56) LTA4HRECQLKDM4ERNF4POLB
SCHEMBL5659377 0.90 LTA4H (0.63) LTA4HRECQLKDM4ERNF4HDAC1
SCHEMBL5659647 0.89 LTA4H (0.62) LTA4HRECQLKDM4ERNF4HDAC1
SCHEMBL5661814 0.89 LTA4H (0.62) LTA4HRECQLKDM4ERNF4HDAC1
SCHEMBL579763 0.87 OPRM1 (0.54) RECQLALDH1A1SMN1; SMN2NPY5RLMNA
SCHEMBL22069565 0.87 RECQL (0.75) LTA4HRECQLKDM4ERNF4HDAC1
SCHEMBL579645 0.87 MEN1 (0.56) RECQLKDM4ERNF4HDAC1ALDH1A1
SCHEMBL5661530 0.86 LTA4H (0.61) LTA4HRECQLKDM4ERNF4HDAC1
SCHEMBL5657528 0.85 TAAR1 (0.59) LTA4HRECQLKDM4EPOLBMEN1
SCHEMBL5660688 0.85 LTA4H (0.60) LTA4HRECQLKDM4ERNF4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155727-A1 Amide inhibitors of leukotriene A4 hydrolase SCHERING AKTIENGESSELLSCHAFT (DE) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155727-A1 Amide inhibitors of leukotriene A4 hydrolase LTA4H, LTB4R, LTC4S LTA4H 1/4885RECQL 161/4885KDM4E 1019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.